Synthesis of 2-alkynylcordycepins and evaluation of their vasodilating activity

Nucleosides and Nucleotides

Volumn 17, Issue 1-3, 1998, Pages 15-27

  Kumamoto, Hiroki ^a   Hayakawa, Hiroyuki ^a   Tanaka, Hiromichi ^a   Shindoh, Satoru ^a   Kato, Keisuke ^a   Miyasaka, Tadashi ^a   Endo, Kazuki ^b   Machida, Haruhiko ^b   Matsuda, Akira ^c  

^a SHOWA UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 OCTYN 1 YL)CORDYCEPIN; ADENOSINE DERIVATIVE; CORDYCEPIN DERIVATIVE; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG SYNTHESIS; FEMORAL ARTERY; FEMORAL VEIN; VASODILATATION;

EID: 0031952514     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808005154     Document Type: Article

References (26)

1. For a review concerning nucleoside antibiotics, see: Isono, K. J. Antibiot. 1988, 41, 1711-1739.
2. For a review, see: Srivastava, P. C.; Robins, R. K.; Meyer, R. B., Jr. In Chemistry of Nucleosides and Nucleotides; Townsend, L. B. Ed.; Plenum Press, New York, 1988; Vol. 1, pp. 113-281.
3. For the synthesis of 2-substituted derivatives from purine nucleosides, see: a) Maeda, M.; Nushi, K.; Kawazoe, Y. Tetrahedron 1974, 30, 2677-2682. b) Matsuda, A.; Nomoto, Y.; Ueda, T. Chem. Pharm. Bull 1979, 27, 183-192.
4. For the synthesis of 2-substituted derivatives from purine nucleosides, see: a) Maeda, M.; Nushi, K.; Kawazoe, Y. Tetrahedron 1974, 30, 2677-2682. b) Matsuda, A.; Nomoto, Y.; Ueda, T. Chem. Pharm. Bull 1979, 27, 183-192.
5. a) Nair, V.; Richardson, S. G. Synthesis 1982, 670-672.
6. b) Nair, V.; Young, D. A. J. Org. Chem. 1985, 50, 406-408.
7. Nair, V. Nucleosides Nucleotides 1989, 8, 699-708 and references cited therein.
8. a) Matsuda, A.; Shinozaki, M.; Miyasaka, T.; Machida, H.; Abiru, T. Chem. Pharm. Bull. 1985, 33, 1766-1769.
9. b) Matsuda, A.; Shinozaki, M.; Yamaguchi, T.; Homma, H.; Nomoto, R.; Miyasaka, T.; Watanabe, Y.; Abiru, T. J. Med. Chem. 1992, 35, 241-252.
10. a) Tanaka, H.; Uchida, Y.; Shinozaki, M.; Hayakawa, H.; Matsuda, A.; Miyasaka, T. Chem. Pharm. Bull. 1983, 31, 787-790.
11. b) Hayakawa, H.; Haraguchi, K.; Tanaka, H.; Miyasaka, T. Chem. Pharm. Bull. 1987, 35, 72-79.
12. c) Hayakawa, H.; Tanaka, H.; Haraguchi, K.; Mayumi, M.; Nakajima, M.; Sakamaki, T.; Miyasaka, T. Nucleosides Nucleotides 1988, 7, 121-128.
13. d) Hayakawa, H.; Tanaka, H.; Sasaki, K.; Haraguchi, K.; Saitoh, T.; Takai, F.; Miyasaka, T. J. Heterocycl. Chem. 1989, 26, 189-192.
14. a) Kato, K.; Hayakawa, H.; Tanaka, H.; Kumamoto, H.; Miyasaka, T. Tetrahedron Lett. 1995, 36, 6507-6510.
15. b) Kato, K.; Hayakawa, H.; Tanaka, H.; Kumamoto, H.; Shindoh, S.; Shuto, S.; Miyasaka, T., submitted for publication.
16. For a review concerning the Stille reaction, see: Mitchell, T. N. Synthesis 1992, 803-815.
17. a) Tius, M. A.; Kawakami, J. K. Synth. Commun. 1992, 22, 1461-1471.
18. b) Tius, M. A. Tetrahedron 1995, 51, 6605-6634.
19. Winbury, M. M.; Papierski, D. H.; Hemmer, M. L.; Hambourger, W. E. J. Pharmacol. Exp. Ther. 1953, 109, 255-260.
20. a) Maguire, M. H.; Nobbs, D. M.; Einstein, R.; Middleton, J. C. J. Med. Chem. 1971, 14, 415-420.
21. b) Marumoto, R.; Yoshioka, Y.; Miyashita, O.; Shima, S.; Imai, K.; Kawazoe, K.; Honjo, M. Chem. Pharm. Bull. 1975, 23, 759-774.
22. a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467-4470.
23. b) Heck, R. F. Acc. Chem. Res. 1979, 12, 146-151.
24. 3 was seemingly that of a single isomer, this compound is assumed to be a mixture of two diastereoisomers, as the reagent used was a racemic modification.
25. Zhang, W.; Robins, M. J. Tetrahedron Lett. 1992, 33, 1177-1180.
26. Abiru, T.; Endo, K.; Machida, H. Eur. J. Pharmacol. 1995, 281, 9-15.